Back

FLAGSHIP BIOTECH INTERNATIONAL PRIVATE LIMITED

1204 & 1302, RUPA SOLITAIRE, PLOT A-1, SECTOR 1, MILLENNIUM BUSINESS PARK, MAHAPE, NAVI MUMBAI – 400710, MAHARASHTRA, INDIA

Product Categories

Formulations
ENOXAPARIN (40 MG),LEVOBUPIVACAINE (0.5%),LIDOCAINE (2%) + ADRENALINE (2%),VASOPRESSIN (20 IU)

Company Profile

FLAGSHIP BIOTECH INTERNATIONAL PVT. LTD. (FBIPL) WAS ESTABLISHED IN 2008 AND IS A PHARMACEUTICAL MANUFACTURING AND MARKETING COMPANY BASED IN MUMBAI, INDIA, WITH OVERSEAS OFFICES IN CENTRAL AMERICA. WE SPECIALIZE IN INJECTABLE, OPHTHALMIC, ORAL, TOPICAL, AND PARENTERAL DOSAGE FORMS, WITH 1000+ PRODUCT REGISTRATIONS ACROSS MULTIPLE INTERNATIONAL MARKETS. OUR EXISTING FACILITY IS APPROVED BY MOH NIGERIA, NMRA SRI LANKA, AND MOH SYRIA, WHILE APPROVALS FROM A FEW OTHER REGULATORY AUTHORITIES ARE CURRENTLY AWAITED. ADDITIONALLY, WE ARE SETTING UP A NEW STATE-OF-THE-ART MANUFACTURING FACILITY IN GUJARAT, INDIA, WHICH WILL COMMENCE OPERATIONS IN Q4 2026. THE FACILITY WILL FOCUS ON INJECTABLE AND OPHTHALMIC FORMULATIONS AND IS BEING DESIGNED TO MEET GLOBAL REGULATORY AND SUSTAINABILITY STANDARDS, WITH THE OBJECTIVE OF OBTAINING EU-GMP AND USFDA APPROVALS.